(Q73305667)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

M Weiser

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Shneider-Beeri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Nakash

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Brill

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

O Bawnik

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Reiss

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Hocherman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Davidson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Schizophrenia Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

81-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Cognitive function in Parkinson's disease: From description to theory

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Visuomotor transformations: early cortical mechanisms of reaching.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Abnormalities in the distributed network of sustained attention predict neuroleptic treatment response in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Population-based norms for the Mini-Mental State Examination by age and educational level

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Alternating fluency in Parkinson's disease. An evaluation of the attentional control theory of cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Course of schizophrenia: neuropsychological evidence for a static encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Wisconsin Card Sorting Test performance in schizophrenia: remediation of a stubborn deficit.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Two-dimensional tracing and tracking in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Visuomotor control abnormalities in patients with unilateral parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Abnormalities of tracking behavior in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

The bioavailability and pharmacokinetics of oral and depot intramuscular haloperidol in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Set-shifting and spatial orientation in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Dissociating executive mechanisms of task control following frontal lobe damage and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Rey Auditory-Verbal Learning Test performance of patients with and without memory impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Disturbed frontal regulation of attention in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

The effect of risperidone on cognition in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Distributed motor processing in cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Visuomotor performance in patients with essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

Contributions of clinical neuropsychology to the study of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900025-6

7 January 2021

10.1016/S0920-9964(00)00025-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11120419%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference